Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
200 participants
OBSERVATIONAL
2007-10-31
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Study of the Linear™ Hip
NCT00764959
Mobile - Bearing Knee Study
NCT00765362
Post-Market Study of the EPIK Knee System
NCT01464632
3DKnee™ System vs. the MJS Knee System
NCT00764803
The 3DKnee™ System: A Post-Market Study
NCT00764673
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Foundation Knee
Retrospective data collection on 510(k) approved device
Foundation Knee
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis who received a primary Foundation Knee replacement and is willing to participate in the study.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Foundation Knee
Subjects with degenerative joint disease (DJD), osteoarthritis or rheumatoid arthritis who received a primary Foundation Knee replacement and is willing to participate in the study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* osteoarthritis
* post-traumatic arthritis
* inflammatory tissue disorders
* arthritis secondary to other diseases
* Avascular necrosis of the femoral condyles;
* Skeletal maturity
* Less than 70 on the Knee Society Score (rating score)
* Sufficient bone stock, as judged by radiographs, to support primary knee implant
* Sufficient collateral ligaments to support the device, as judged by physician during stability testing (varus/valgus and flexion/extension) and less than 45 degree varus/valgus deformity and/or 90 degree flexion contracture
* Patient is likely to be available for evaluation for the duration of the study
* Able and willing to sign the informed consent and follow study procedures
* Patient is not pregnant
* No infection present
* No known materials sensitivity
Exclusion Criteria
* Greater than or equal to 70 on preoperative Knee Society Score (Rating Score)
* Post-patellectomy
* Insufficient bone quality which may affect implant stability
* Insufficient collateral ligaments, as judged by the physician. Greater than 45 degree varus/valgus deformity and/or 90 degree flexion contracture.
* Neurological conditions that might hinder patient's ability to follow study procedures (i.e., any that restrict physical activities such as Parkinson's Disease, Multiple Sclerosis, previous stroke which affects lower extremity)
* Mental conditions that may interfere with ability to give an informed consent or willingness to fulfill the study requirements (i.e., severe mental retardation such that the patient cannot understand the informed consent process, global dementia, prior strokes that interfere with the patient's cognitive abilities, senile dementia, and Alzheimer's Disease)
* Prisoners
* Conditions that place excessive demand on the implant (i.e. Charcot's joints, muscle deficiencies, refusal to modify postoperative physical activities, skeletal immaturity)
* Patient is pregnant
* Infection present
* Materials sensitivity
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Encore Medical, L.P.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
DJO Surgical
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Omar Hussamy, M.D.
Role: PRINCIPAL_INVESTIGATOR
Hussamy Orthopedics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hussamy Orthopedics
Vero Beach, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Sponsor Company home page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PS - 701
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.